Evidence map›Paper›PMID 30408431›Full record

ReviewSexual health2018

Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.

Megan S Dunbar, Katharine Kripke, Jessica Haberer, Delivette Castor, Shona Dalal, Wanjiru Mukoma, Saiqa Mullick, Pragna Patel, Jason Reed, Hasina Subedar and 3 more

Abstract readReview
In one paragraph

Review in Sexual health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Megan S DunbarFHI 360, 359 Blackwell Street, Suite 200, Durham, NC 27701, USA.
Katharine KripkeAvenir Health, 7064 Eastern Avenue, NW, Washington, DC 20012, USA.
Jessica HabererMassachusetts General Hospital Center for Global Health, 125 Nashua Street, Suite 722, Boston, MA 02114, USA.
Delivette CastorOffice of HIV/AIDS, Bureau for Global Health, USAID, 1300 Pennsylvania Avenue, Washington, DC, 20004, USA.
Shona DalalWorld Health Organization, Avenue Appia 20, Geneva 1211, Switzerland.
Wanjiru MukomaLVCT Health, Argwings Kodhek Road, PO Box 19835-00202 KNH, Nairobi, Kenya.
Saiqa MullickWits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, 22 Esselen Street, Hillbrow Health Precinct, Johannesburg 2001, South Africa.
Pragna PatelCenters for Disease Control and Prevention, Center for Global Health, Division of Global HIV and TB, 1600 Clifton Road, MS E-04, Atlanta, GA 30333, USA.
Jason ReedJhpiego, 1615 Thames Street, Baltimore, MD 21231, USA.
Hasina SubedarSouth Africa National Department of Health, Civitas Building, 222 Thabo Sehume Street, CBD, Pretoria, 0001, South Africa.
Daniel WereJhpiego, 14 Riverside, off Riverside Drive, 2nd Floor, Arlington Block, PO Box 66119-00800, Nairobi, Kenya.
Mitchell WarrenAVAC, 423 West 127th Street, 4th floor, New York, NY 10027, USA.
Kristine TorjesenFHI 360, 359 Blackwell Street, Suite 200, Durham, NC 27701, USA.

Funding

Intramural CDC HHS CC999999PEPFARWorld Health Organization 001
6 · The paper itself

Abstract

In response to World Health Organization (WHO) guidance recommending oral pre-exposure prophylaxis (PrEP) for all individuals at substantial risk for HIV infection, significant investments are being made to expand access to oral PrEP globally, particularly in sub-Saharan Africa. Some have interpreted early monitoring reports from new programs delivering oral PrEP to adolescent girls and young women (AGYW) as suggestive of low uptake. However, a lack of common definitions complicates interpretation of oral PrEP uptake and coverage measures, because various indicators with different meanings and uses are used interchangeably. Furthermore, operationalising these measures in real-world settings is challenged by the difficulties in defining the denominator for measuring uptake and coverage among AGYW, due to the lack of data and experience required to identify the subset of AGYW at substantial risk of HIV infection. This paper proposes an intervention-centric cascade as a framework for developing a common lexicon of metrics for uptake and coverage of oral PrEP among AGYW. In codifying these indicators, approaches to clearly define metrics for uptake and coverage are outlined, and the discussion on 'low' uptake is reframed to focus on achieving the highest possible proportion of AGYW using oral PrEP when they need and want it Recommendations are also provided for making increased investments in implementation research to better quantify the sub-group of AGYW in potential need of oral PrEP.and for improving monitoring systems to more efficiently address bottlenecks in the service delivery of oral PrEP to AGYW so that implementation can be taken to scale.

Indexed as

Drug MonitoringAdministration, OralAdolescentAfrica South of the SaharaAnti-HIV AgentsFemaleHIV InfectionsHumansPre-Exposure ProphylaxisYoung AdultAnti-HIV Agents

Identifiers

PMID30408431
PMCPMC6429961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.